Market Share of Global Clinical Oncology NGS Industry
The clinical oncology next-generation sequencing (NGS) market is highly competitive, with several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the market are Illumina, Inc., Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Agilent Technologies, Myriad Genetics, Beijing Genomics Institute (BGI), Perkin Elmer.
Clinical Oncology NGS Market Leaders
Illumina, Inc.
Thermo Fisher Scientific
F. Hoffmann-La Roche Ltd.
Agilent Technologies
Myriad Genetics
*Disclaimer: Major Players sorted in no particular order
